Company Valuation: American Oncology Network, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024
Market Cap 1 - - 56.35 137.1
Change - - - 143.33%
Enterprise Value (EV) - - 125.3 215.2
Change - - - 71.77%
P/E - - -4.32x -5.7x
PBR - - -0.35x -3.31x
PEG - - - 0.2x
Capitalization / Revenue - - 0.04x 0.08x
EV / Revenue - - 0x 0x
EV / EBITDA - - -0x -0x
EV / EBIT - - -0x -0x
EV / FCF - - - -
FCF Yield - - - -
Dividend per Share 2 - - - -
Rate of return - - - -
EPS 2 - - -1.365 -0.8874
Distribution rate - - - -
Net sales 1 943.7 1,150 1,279 1,759
EBITDA 1 6.99 12.28 -4.668 -5.575
EBIT 1 0.911 5.566 -13.12 -16.09
Net income 1 -0.105 2.589 -5.542 -3.973
Net Debt 36.34 91.97 68.94 78.1
Reference price 2 9.75 10.04 5.90 5.06
Nbr of stocks (in thousands) - - 9,550 27,096
Announcement Date 1/6/23 4/28/23 3/28/24 3/27/25
1USD in Million2USD
Estimates

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 405M
16.99x0.47x10.14x2.5% 136B
12.88x1.68x8.32x0.8% 85.57B
12.5x1.44x8.69x2.72% 26.95B
21.79x2.37x11.98x1.53% 23.18B
29.28x5.39x22.74x2.38% 20.05B
7.89x1.25x5.9x-.--% 17.16B
15.97x1.49x7.6x4.44% 15.47B
16.01x1.83x8.8x0.71% 15.02B
14.12x1.02x5.72x3.27% 12.78B
Average 16.38x 1.88x 9.99x 2.04% 35.25B
Weighted average by Cap. 16.03x 1.40x 9.89x 1.95%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. AONC Stock
  4. Valuation American Oncology Network, Inc.